Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-797-1 | CAS number: 696-59-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 29-Jun-2018 to 03-Sept-2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- Tetrahydro-2,5-dimethoxyfuran
- EC Number:
- 211-797-1
- EC Name:
- Tetrahydro-2,5-dimethoxyfuran
- Cas Number:
- 696-59-3
- Molecular formula:
- C6H12O3
- IUPAC Name:
- tetrahydro-2,5-dimethoxyfuran
- Test material form:
- liquid
Constituent 1
In chemico test system
- Details on the study design:
- Formulation of the Test Item: 100 mM in acetonitrile (a homogenous and clear solution was formed) (prepared just before use)
Positive Control: Cinnamaldehyde
Peptide solutions: Cysteine and lysine peptide stock solutions were prepared at the concentrations of 0.501 mg/mL and 0.518 mg/mL with sodium phosphate buffer (pH=7.5) and ammonium acetate buffer (pH=10.2) respectively. Calibration standards were made by serial dilutions from these peptide stock solutions. The test chemical stock solutions were combined with the peptide stock solutions (1:10 and 1:50 ratio with cysteine and lysine peptides respectively) as reaction samples.
HPLC System Conditions:
- HPLC system: SHIMADZU LC2030 (Prominence-i LC-2030C)
- Serial number: L21445402951AE
- Column: Zorbax SB-C18 (2.1 x 100 mm, 3.5 μm)
- Serial number: USRY003976
- Column temperature: 30°C
- Sample temperature: 25°C
- Detector: 220 nm (258 nm)
- Injection volume: 7μL
- System equilibration: 50% phase A (0.1 % v/v trifluoroacetic acid in ultra-pure water) and 50% phase B (0.085 % v/v trifluoroacetic acid in acetonitrile) for 2 hours at 30°C and running the gradient twice before injecting the first sample
- Run time: 20 min
- Flow conditions: gradient flow
Percent peptide depletion:
The concentration of the peptide was determined in each reaction sample from absorbance at 220 nm, measuring the peak area of the appropriate peaks and calculating the concentration of the peptide using the linear calibration curves derived from the standards.
The percent peptide depletion was determined in each reaction sample and positive control sample measuring the quotient of the peak area and the mean reference control peak area.
Assigning the test chemical to a reactivity class and category:
The average percent peptide depletion was calculated for the test item. By using the cysteine 1:10 / lysine 1:50 prediction model (see table below), the threshold of 6.38% average peptide depletion was used to support the discrimination between a skin sensitizer and a non-sensitizer. On the basis of the prediction model, chemicals assigned to the minimal reactivity class should be classified as non-sensitisers whereas chemicals assigned to the low, moderate or high reactivity class should be classified as sensitisers:
- No or minimal reactivity: Mean % depletion < 6.38%
- Low reactivity: 6.38% < Mean % depletion < 22.62%
- Moderate reactivity: 22.62% < Mean % depletion < 42.47%
- High reactivity: 42.47% < Mean % depletion < 100%
Results and discussion
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: mean (3 replicates)
- Parameter:
- other: % cysteine peptide depletion
- Value:
- 5.64
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: mean (3 replicates)
- Parameter:
- other: % lysine peptide depletion
- Value:
- 1.05
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Table 1. Cysteine peptide depletion values for the positive control and the test item
Name, replicate number |
Peptide peak area at 220 nm |
Peptide conc. calculated (mM) |
Peptide depletion |
|
% |
SD (%) |
|||
ref ControlAcetonitril, rep I |
1709414 |
0.48 |
- |
- |
ref ControlAcetonitril, rep II |
1826152 |
0.51 |
- |
|
ref ControlAcetonitril, rep III |
1602686 |
0.45 |
- |
|
2,5-Dimethoxytetrahydrofuran, rep I |
1702104 |
0.48 |
0.43 |
5.11 |
2,5-Dimethoxytetrahydrofuran, rep II |
1631700 |
0.46 |
10.65 |
|
2,5-Dimethoxytetrahydrofuran, rep III |
1509173 |
0.42 |
5.83 |
|
CINNAMALDEHYDE, rep I |
550299 |
0.15 |
67.81 |
2.03 |
CINNAMALDEHYDE, rep II |
532919 |
0.15 |
70.82 |
|
CINNAMALDEHYDE, rep III |
529501 |
0.15 |
66.96 |
Table 2. Lysine peptide depletion values for the positive control and the test item
Name, replicate number |
Peptide peak area at 220 nm |
Peptide conc. calculated (mM) |
Peptide depletion |
|
% |
SD (%) |
|||
ref ControlAcetonitril, rep I |
2423559 |
0.50 |
- |
- |
ref ControlAcetonitril, rep II |
2423810 |
0.50 |
- |
|
ref ControlAcetonitril, rep III |
2427200 |
0.50 |
- |
|
2,5-Dimethoxytetrahydrofuran, rep I |
2379022 |
0.49 |
1.84 |
0.89 |
2,5-Dimethoxytetrahydrofuran, rep II |
2421761 |
0.50 |
0.08 |
|
2,5-Dimethoxytetrahydrofuran, rep III |
2397130 |
0.50 |
1.24 |
|
CINNAMALDEHYDE, rep I |
1118469 |
0.23 |
53.85 |
2.35 |
CINNAMALDEHYDE, rep II |
1166689 |
0.24 |
51.87 |
|
CINNAMALDEHYDE, rep III |
1233686 |
0.26 |
49.17 |
Table 3. Mean peptide depletion values for the positive control and the test chemical
Name, replicate number |
Obtained mean % cysteine peptide depletion |
Obtained mean % lysine peptide depletion |
Mean % obtained peptide depletion |
2,5-Dimethoxytetrahydrofuran |
5.64 |
1.05 |
3.35 |
CINNAMALDEHYDE |
68.53 |
51.63 |
60.08 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this assay, 2,5 Dimethoxytetrahydrofuran has no or minimal reactivity towards the synthetic peptides, thus is not a potential skin sensitizer.
- Executive summary:
This study was undertaken to evaluate the skin sensitization potential of the test item 2,5-Dimethoxytetrahydrofuran in chemico. The Direct Peptide Reactivity Assay (DPRA) according to OECD TG 442C was used.
The positive control replicates showed the expected percent peptide depletion values within acceptable limits (65.53% with cysteine peptide and 51.63 % mean percent lysine peptide depletion). The back-calculated values of the reference control replicates were within the expected molarity concentration range of 0.50 ± 0.05 mM. The experiment was considered to be valid.
The percent cysteine peptide depletion value of 2,5-Dimethoxytetrahydrofuran was 5.64 % while the percent lysine peptide depletion was 1.05 %. The Cysteine 1:10 / Lysine 1:50 prediction model was used for the discrimination between sensitisers and non-sensitisers based on the threshold of 6.38 %. The average percent peptide depletion value of the test item was 3.35 % which does not exceed the threshold.
Results obtained from this in chemico Direct Peptide Reactivity Assay with the test item 2,5 Dimethoxytetrahydrofuran indicated that the test item has no or minimal reactivity towards the synthetic peptides, thus is not a potential skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.